Symbols

PIII

P3 Health Partners·NASDAQ

--(--)

PIII fundamentals

PIII Q4 2025 Earnings

P3 Health Partners (PIII) released its earnings on Mar 26, 2026: revenue was 384.81M (YoY +3.81%), beat estimates; EPS was -23.02 (YoY -27.89%), missed estimates.

Revenue / YoY

384.81M

+3.81%

EPS / YoY

-23.02

-27.89%

Report date

Mar 26, 2026

PIII Earnings Call Summary for Q4,2025

2026 EBITDA Target: $10M (midpoint of -$20M to $40M range), up $170M from 2025 loss
Revenue Growth Driver: 29,000 new Nebraska members adding $27M in 2026 revenue
Cost Efficiency: 75% of $170M improvement already embedded in Q1 2026 through CMS rate hikes and contract renegotiations
Operational Focus: Scaling MedEx initiatives and delegated functions in Nebraska to reduce risk volatility
Financial Discipline: $10M YoY operating expense reduction in 2025; disciplined reinvestment in frontline operations

Earnings

EPS

Revenue

Revenue & Expenses

PIII has released its 2025 Q4 earnings report, with revenue of 384.81M, reflecting a YoY change of 3.81%, and net profit of -165.71M, showing a YoY change of -28.31%. The Sankey diagram below clearly presents PIII's revenue sources and cost distribution.

Key Indicators

P3 Health Partners (PIII) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

P3 Health Partners (PIII)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

P3 Health Partners (PIII)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

P3 Health Partners (PIII)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown